Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/5242
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorSilva, C. Rocha da Silva-
dc.contributor.authorCampos, R. de Sousa-
dc.contributor.authorSantos Neta, M. Adalgiza dos-
dc.contributor.authorÂngelo, M. Rozellê Ferreira-
dc.contributor.authorMagalhães, H. Iury Ferreira-
dc.contributor.authorCavalcanti, B. Coêlho-
dc.contributor.authorMoraes Filho, Manoel Odorico de-
dc.contributor.authorMacedo, D. Silveira-
dc.contributor.authorNobre Júnior, Hélio Vitoriano-
dc.date.accessioned2013-07-04T16:14:55Z-
dc.date.available2013-07-04T16:14:55Z-
dc.date.issued2011-12-
dc.identifier.citationSILVA,C. R. et al. Susceptibility to caspofungin of Candida spp. strains isolated in Ceará,Northeastern Brazil. Journal de Mycologie Médicale, v. 21, n. 4, p. 273-276, dez., 2011.pt_BR
dc.identifier.issn1156-5233-
dc.identifier.urihttp://www.repositorio.ufc.br/handle/riufc/5242-
dc.description.abstractCaspofungin is an echinocandin prescribed for the treatment of invasive fungal infections caused by Candida spp. and Aspergillus spp. The aim of this study is to assess thedegree of susceptibility of Candida spp., isolated from blood cultures in the state of Ceará (Brazil) to caspofungin by the broth microdilution method. Thirty-three strains of Candida spp. were selected for the test (seven C. albicans, nine C. tropicalis and 17 C. parapsilosis); these strains are the most commonly isolates of fungal infections in Ceará. The results of susceptibility tests by broth microdilution can be read at 24 or 48 hours after testing, without compromising test interpretations. C. parapsilosis exhibited the highest MICs when compared with the MICs of caspofungin against C. albicans and C. tropicalis.pt_BR
dc.language.isoenpt_BR
dc.publisherJournal de Mycologie Médicalept_BR
dc.subjectCandidapt_BR
dc.subjectAspergilluspt_BR
dc.titleSusceptibility to caspofungin of Candida spp. strains isolated in Ceará, Northeastern Brazilpt_BR
dc.typeArtigo de Periódicopt_BR
dc.description.abstract-frLa caspofungine est une échinocandine prescrite pour le traitement des infections fongiques invasives causées par Candida sp. et Aspergillus sp. Le but de cette étude est d’évaluer le degré de sensibilité à la caspofungine de Candida sp., isolé à partir d’hémocultures dans l’état du Ceará (Brésil) par la méthode de microdilution. Trente-trois souches de Candida sp. ont été sélectionnées pour le test (sept C. albicans, neuf C. tropicalis et 17 C. parapsilosis) ; ces souches sont le plus souvent isolées dans des infections fongiques en Ceará. Les résultats des tests de sensibilité par microdilution peuvent être lus à 24 ou 48 heures après les tests, sans compromettre les interprétations du test. C. parapsilosis montre les CMI les plus élevées comparativement à celles de C. albicans et C. tropicalis pour la caspofungine.pt_BR
Aparece nas coleções:DMC - Artigos publicados em revistas científicas

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2011_art_masantosneta.pdf247,84 kBAdobe PDFVisualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.